Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5

LONDON, Oct. 30, 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2020 financial results and operational highlights before open of U.S. markets on Thursday, November 5, 2020.

Management will host a conference call and webcast at 8:30 am ET/1:30 pm GMT to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to: https://www.autolus.com/investor-relations/news-and-events/events.

The call may also be accessed by dialing [phone] for U.S. and Canada callers or [phone] for international callers. Please reference conference ID 5562455. After the conference call, a replay will be available for one week. To access the replay, please dial [phone] for U.S. and Canada callers or [phone] for international callers. Please reference conference ID 5562455.

Contact:

Lucinda Crabtree, PhD
Vice President, Investor Relations and Corporate Communications
[phone]
[e-mail]

Julia Wilson
[phone]
[e-mail]

Susan A. Noonan
S.A. Noonan Communications
[phone]
[e-mail]